Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 17
- Interviews
Why Curaleaf Laboratories Believes the UK Medical Cannabis Market Is Still Just Getting Started
As the UK’s medical cannabis patient population pushes past an estimated 60,000, questions about market maturity, patient access, and regulatory reform are more pressing than ever.
- UK & Europe
Landmark Turkish Bill Legalises Low THC Cannabis Sales in Pharmacies
As reported by Turkiye Today, the Turkish parliament has now passed the proposed legislative package, introducing significant reforms to the healthcare system, including the regulated sale of medical cannabis in pharmacies.
- Industry Trends
Why the UK’s Steady Medical Cannabis Market Growth Is Its Biggest Advantage
Though less explosive than markets like Germany or Australia, the UK has continued to evolve in a more controlled manner, enabling it to largely avoid the scrutiny and intervention that have accompanied rapid expansion elsewhere.
- Medical Cannabis
Czech Republic to Decriminalise Cannabis from 2026 — But Medical Exports Already Booming
The Czech Republic has been pursuing a more relaxed cannabis policy for some time. In early June, the lower house of parliament approved a draft law amounting to partial legalisation. The Senate followed suit at the start of July, meaning cannabis will be fully decriminalised from 1 January next year.
- Industry Trends
Has Germany’s Medical Cannabis Market Peaked? New Laws, Surging Supply, and Industry Unrest
Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across Europe and beyond.
- Patient Access
The Polish Pivot: What Happens When Telehealth Meets Regulation
Some see Poland’s telemedicine crackdown as a cautionary tale, others see its subsequent rebound as a beacon of hope. Regardless, it now appears to be the new reality for developing medical cannabis markets.
- Medical Cannabis
‘Valuable’ UK Medical Cannabis Data to be Published After A Four Year Delay
The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end of the year’.
- International Regulation
Victim of Its Own Success?: German & Australian Regulators Crackdown on Booming Cannabis Telemedicine Sector
Germany’s Ministry of Health has now published a long-feared draft amendment to its Medical Cannabis Act (MedCanG), threatening a crackdown which will be a major cause for concern for hundreds of cannabis businesses, both in and outside of German borders.
- M&A Activity
Grow Group’s Avida Acquisition Marks Bold Step Forward for UK Cannabis Stalwart
Grow Group, one of the UK’s leading medical cannabis distributors now supplying over 10,000 patients internationally, announced a major strategic shift to bring control of its operations entirely in house.
- Patient Access
Cannabis Telemedicine is Becoming Even More Popular in Germany, Especially in Rural Areas
It is not clear how the new Drugs Commissioner will react to the blistering growth of telemedicine, but it is clear that patients would suffer most should access be tightened.
- Your #1 Podcast on Cannabis News
Podcast: Special Ed. | From Anecdote to Evidence: Data for Advanced Access | Releaf & Dr Anne Katrin Schlag
In this special edition of the Business of Cannabis Podcast, we go From Anecdote to Evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf.
- Patient Access
US House Votes to Allow VA Doctors to Recommend Medical Cannabis in Landmark Veterans Health Bill
Doctors at the US Department of Veterans Affairs (VA) may soon be allowed to recommend medical cannabis to patients, following the passage of a landmark House spending bill that seeks to align federal veterans’ care with state-level cannabis laws.
